Clinical Application of Recombinant Human Bone Morphogenetic Protein‐2 in 4 Dogs

Abstract

Direct intraoperative administration or fluoroscopically guided, minimally invasive delivery of rhBMP-2 may be an effective treatment modality for bone delayed- or nonunions and could potentially be used to stimulate new bone production in a variety of orthopedic surgical conditions in dogs.